Tao Liu, Ph.D.
Vice President, Head of Chemistry
Boston, Massachusetts, United States
Professional Overview
Tao Liu, Ph.D., is an accomplished pharmaceutical executive with over 15 years of experience in the drug discovery and development industry. As the Vice President and Head of Chemistry at Ensem Therapeutics, he leads a team of talented scientists in the research and development of innovative small-molecule therapeutics, with a focus on oncology and rare diseases.
Experience Summary
Current Role
As the Vice President and Head of Chemistry at Ensem Therapeutics, Dr. Liu is responsible for overseeing the company's medicinal chemistry efforts, which are critical in the discovery and optimization of novel drug candidates. He manages a team of skilled chemists, collaborating closely with cross-functional partners in biology, pharmacology, and DMPK to advance promising compounds through the drug development pipeline. Under his leadership, Ensem Therapeutics has successfully progressed multiple drug candidates into clinical trials, demonstrating his ability to drive impactful research programs.
Career Progression
Prior to joining Ensem Therapeutics, Dr. Liu held various leadership roles in the pharmaceutical industry, including Research Fellow/Director of Medicinal Chemistry and Associate Director at Agios Pharmaceuticals, as well as positions of increasing responsibility at Infinity Pharmaceuticals, where he rose from Research Scientist to Lead Senior Scientist and Research Associate Director. Throughout his career, he has demonstrated a track record of delivering high-quality research, leading cross-functional teams, and contributing to the advancement of drug candidates into clinical development.
Academic Background
Dr. Tao Liu holds a Ph.D. in Organic Chemistry from the University of Wisconsin-Madison, where he conducted groundbreaking research in the field of synthetic methodology and natural product synthesis. His academic achievements include several peer-reviewed publications in prestigious journals and recognition from the American Chemical Society.
Areas of Expertise
- Medicinal chemistry and small-molecule drug discovery
- Oncology and rare disease drug development
- Synthetic methodology and chemical optimization
- Cross-functional team leadership and collaboration
- Strategic planning and project management
Professional Impact
During his tenure at Agios Pharmaceuticals, Dr. Liu played a pivotal role in the discovery and development of a novel targeted therapy for acute myeloid leukemia, which successfully progressed through clinical trials and received regulatory approval. At Ensem Therapeutics, he has established a robust chemistry platform, accelerating the advancement of multiple drug candidates into clinical development for the treatment of various cancer subtypes and rare genetic disorders.
Conclusion
With his extensive experience, technical expertise, and proven leadership abilities, Dr. Tao Liu is a valuable asset to the pharmaceutical industry. In his current role as Vice President and Head of Chemistry at Ensem Therapeutics, he continues to drive innovative research and development efforts, contributing to the company's mission of delivering transformative therapies to patients in need.
